114 related articles for article (PubMed ID: 16043766)
1. Transcutaneous gases determination in diabetic critical limb ischemia.
Melillo E; Ferrari M; Balbarini A; Pedrinelli R
Diabetes Care; 2005 Aug; 28(8):2081-2. PubMed ID: 16043766
[No Abstract] [Full Text] [Related]
2. [Medical therapy in critical lower limb ischemia when immediate revascularization is not feasible].
Melillo E; Nuti M; Buttitta F; Balbarini A
G Ital Cardiol (Rome); 2006 May; 7(5):317-35. PubMed ID: 16752515
[TBL] [Abstract][Full Text] [Related]
3. Iloprost in the management of peripheral arterial disease in patients with diabetes mellitus.
Piaggesi A; Vallini V; Iacopi E; Tedeschi A; Scatena A; Goretti C; Rizzo L
Minerva Cardioangiol; 2011 Feb; 59(1):101-8. PubMed ID: 21285935
[TBL] [Abstract][Full Text] [Related]
4. [Randomized placebo-controlled studies of iloprost in treatment of lower limb critical ischaemia].
Kharazov AF
Angiol Sosud Khir; 2010; 16(3):27-33. PubMed ID: 21280291
[TBL] [Abstract][Full Text] [Related]
5. Tolerance of Iloprost and results of treatment of chronic severe lower limb ischaemia in diabetic patients. A retrospective study of 64 consecutive cases.
Duthois S; Cailleux N; Benosman B; Lévesque H
Diabetes Metab; 2003 Feb; 29(1):36-43. PubMed ID: 12629446
[TBL] [Abstract][Full Text] [Related]
6. Transcutaneous oxygen and carbon dioxide levels with iloprost administration in diabetic critical limb ischemia.
Melillo E; Ferrari M; Balbarini A; Pedrinelli R
Vasc Endovascular Surg; 2006; 40(4):303-11. PubMed ID: 16959724
[TBL] [Abstract][Full Text] [Related]
7. Pharmacological interventions on critical limb ischemia in diabetic patients.
Parekh N; Nanjundappa A; Dieter RS
J Cardiovasc Surg (Torino); 2012 Feb; 53(1):39-43. PubMed ID: 22231528
[TBL] [Abstract][Full Text] [Related]
8. [Critical ischemia in elderly patients. Evaluation of the effect of two different methods of Iloprost therapy on the efficacy, tolerance, modification of quality of life and self-sufficiency].
Cappelli R; Bicchi M; Arrigucci S; Boschi S; Guerrini M; Forconi S
Minerva Cardioangiol; 1999 Mar; 47(3):81-8. PubMed ID: 10389449
[TBL] [Abstract][Full Text] [Related]
9. Use of stable prostacyclin analogue ZK 36 374 to treat severe lower limb ischaemia.
Chiesa R; Vicari A; Mari G; Galimberti M; Di Carlo V; Pozza G
Lancet; 1985 Jul; 2(8446):95-6. PubMed ID: 2409417
[No Abstract] [Full Text] [Related]
10. Improved peripheral perfusion during endothelin--a receptor blockade in patients with type 2 diabetes and critical limb ischemia.
Kalani M; Pernow J; Bragd J; Jörneskog G
Diabetes Care; 2008 Jul; 31(7):e56. PubMed ID: 18594055
[No Abstract] [Full Text] [Related]
11. [Effectiveness of prostanoids in patients with critical leg ischemia].
Brodszky V; Farkas K; Járai Z; Landi A; Pécsvárady Z; Baji P; Balogh O; Gulácsi L; Péntek M
Orv Hetil; 2011 Dec; 152(51):2047-55. PubMed ID: 22130202
[TBL] [Abstract][Full Text] [Related]
12. Is it possible to improve outcome in patients undergoing surgery for acute limb ischemia? Can iloprost, a prostacyclin analogue, be helpful?
de Donato G; Gussoni G; de Donato G
Chir Ital; 2004; 56(6):769-80. PubMed ID: 15771029
[TBL] [Abstract][Full Text] [Related]
13. Is transcutaneous oxygen and carbon dioxide monitoring indispensable in short- and long-term therapeutic management of non-reconstructable lower critical limb ischemia?
Melillo E; Nuti M; Pedrinelli R; Buttitta F; Balbarini A
Minerva Cardioangiol; 2006 Aug; 54(4):481-98. PubMed ID: 17016419
[TBL] [Abstract][Full Text] [Related]
14. Iloprost and peripheral arterial disease in diabetic patients.
Vicari AM; Chiesa R; Mari G; Galimberti M; Di Carlo V; Pozza G
Acta Diabetol Lat; 1991; 28(1):113-4. PubMed ID: 1713729
[No Abstract] [Full Text] [Related]
15. Ropivacaine infusion in diabetics subject with peripheral arterial disease. A prospective study.
Di Minno MN; Milone M; Russolillo A; Lupoli R; Di Minno A; Maietta P; Iacovazzo C; Salvatore G; Milone F
Exp Clin Endocrinol Diabetes; 2013 Feb; 121(2):91-3. PubMed ID: 23147211
[TBL] [Abstract][Full Text] [Related]
16. [The effect of antiaggregants on the course of diabetic microangiopathy].
Bokarev IN; Velikov VK; Zelenchuk NM; Shubina OI; Saltykov BB; Frolova AI; Polunin GS; Pirogova EP; Nikol'skaia VV; Davydova NG
Ter Arkh; 1993; 65(3):78-81. PubMed ID: 8059393
[TBL] [Abstract][Full Text] [Related]
17. [Plasmapheresis in the treatment of critical stages of ischemia in diabetic angiopathy of the lower extremities].
Georgadze AK; Sokolov SS; Gvozdev NA; Postnikov AA; Sharandak AP
Vestn Khir Im I I Grek; 1989 Mar; 142(3):20-4. PubMed ID: 2749988
[TBL] [Abstract][Full Text] [Related]
18. Regulation of VEGF in diabetic patients with critical limb ischemia.
Hochberg I; Hoffman A; Levy AP
Ann Vasc Surg; 2001 May; 15(3):388-92. PubMed ID: 11414092
[TBL] [Abstract][Full Text] [Related]
19. Impaired hemorheological properties in diabetic patients with lower limb arterial ischaemia.
Le Devehat C; Khodabandehlou T; Vimeux M
Clin Hemorheol Microcirc; 2001; 25(2):43-8. PubMed ID: 11790869
[TBL] [Abstract][Full Text] [Related]
20. Effects of iloprost and factors affecting outcome in patients with severe inoperable lower limb ischaemia. U.K. Severe Limb Ischaemia Study Group.
Belcher G
Agents Actions Suppl; 1992; 37():354-60. PubMed ID: 1378690
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
